Related Experiment Video
Updated: Apr 21, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
A short contemporary history of disseminated intravascular coagulation
Marcel Levi1, Tom van der Poll1
1Department of Medicine, University of Amsterdam, Amsterdam, The Netherlands.
Insights
Disseminated intravascular coagulation (DIC) is a critical condition involving widespread fibrin deposition, potentially causing organ failure. Current understanding shows tissue factor expression, not contact activation, initiates DIC, complicated by impaired anticoagulation and fibrinolysis.
Area of Science:
- Hematology
- Pathophysiology
- Medical Science
Background:
- Disseminated intravascular coagulation (DIC) is a complex syndrome known for centuries.
- Historically, misconceptions existed regarding its primary triggers and associated fibrinolytic responses.
Observation:
- DIC involves systemic activation of coagulation and widespread fibrin deposition in circulation.
- This process can lead to depletion of platelets and coagulation factors, resulting in consumption coagulopathy and bleeding.
Findings:
- Experimental and clinical evidence refutes the contact activation system as the primary trigger for DIC.
- Tissue factor expression is now recognized as the initiator of coagulation in DIC.
- Downregulated anticoagulant pathways and impaired fibrinolysis, alongside inflammation, contribute significantly to DIC pathogenesis.
Implications:
- Accurate understanding of DIC mechanisms is crucial for effective treatment strategies.
- Targeting tissue factor and modulating inflammatory responses may offer therapeutic avenues.
- Further research into the interplay between coagulation and inflammation can improve patient outcomes in DIC.
Abstract:
Disseminated intravascular coagulation (DIC) is a syndrome characterized by systemic intravascular activation of coagulation, leading to a widespread deposition of fibrin in the circulation. There is ample experimental and pathological evidence that the fibrin deposition contributes to multiple organ failure. The massive and ongoing activation of coagulation may result in depletion of platelets and coagulation factors, which may cause bleeding (consumption coagulopathy). The syndrome of DIC is well known in the medical literature for centuries, although a more precise description of the underlying mechanisms had to await the 20th century. Initial ideas on a role of the contact activation system as the primary trigger for the systemic activation of coagulation as well as a presumed hyperfibrinolytic response in DIC have been found to be misconceptions. Experimental and clinical evidence now indicate that the initiation of coagulation in DIC is caused by tissue factor expression, which in combination with downregulated physiological anticoagulant pathways and impaired fibrinolysis leads to widespread fibrin deposition. In addition, an extensive bidirectional interaction between coagulation and inflammation may further contribute to the pathogenesis of DIC.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

